Press Releases

[MaekyungHealth] Six in Ten Koreans Have Just 0–2 Probiotic Strains Recognized by the Ministry of Food and Drug Safety

[HR Insight] U2XLab: Driving Sustainable Growth through Family-Friendly Policies that Support Employees Throughout Their Life Stages

[ChosunBiz] U2Biome Publishes Gut Microbiome Analysis Results, Confirming Strain Changes Following Personalized Probiotic Intake

[The Chosun Daily] Less Than 50 Employees, Yet “Our Family-Friendly Benefits Rival Those of Large Corporations”

[NewsWire] U2Bio Begins Full-Scale Management of SML Meditree as New CEO Hyuk-sung Jin Takes Office and Company Rebrands as U2XLab

[NewsWire] SML Meditree Signs Strategic Business Agreement with Indonesia’s Equilab

[medifonews] SML Meditree Signs Strategic Business Agreement with JS Link

[NewsWire] SML Meditree Accelerates Expansion in the Global Clinical Trial Sample Analysis Market

[MoneyToday] Protium Science Signs Business Agreement with SML Meditree for Clinical Trial Sample Analysis

[The Yakup] BioSolvix and SML Meditree Sign MOU to Collaborate on Proprietary Technologies

[The Yakup] SML Meditree Signs Strategic Business Agreement with AribNC

[pharmnews] SML Meditree Signs Business Agreement with Medirama